Depression

Showing 100 of 248 articles

Articles in Depression

DEPRESSION

Monitoring Reveals Elevated Antidepressant Levels in Some Waterways

Depression, anxiety and sleep disorders are among the conditions often treated with antidepressant drugs. Yet, up to 90% of these drugs pass through the body into wastewater. They're also difficult to remove during water treatment, presenting a possible risk of environmental contamination and threat

DEPRESSION

BioVie Eyes Summer Catalyst as Parkinson’s, Long COVID Trial Readouts Near

BioVie (NASDAQ:BIVI) President and CEO Cuong Do said during a RedChip Companies webinar that the company expects two near-term clinical readouts for its lead drug candidate, bezisterim, with Parkinson’s disease data anticipated in late July or early August and Long COVID data expected around late Au

DEPRESSION

RFK Jr.’s Push to Curb Antidepressants Has Shaken Psychiatry

Most years, when thousands of psychiatrists gather for the annual meeting of the American Psychiatric Association, they walk past a scattering of protesters. There are Scientologists with megaphones; Falun Gong groups doing their exercises; and, often, former patients, saying they have been harmed b

DEPRESSION

Compass Pathways Q1 Earnings Call Highlights

Compass Pathways (NASDAQ:CMPS) said it has begun a rolling New Drug Application submission for COMP360, its investigational psilocybin treatment for treatment-resistant depression, and is preparing for a potential launch by the end of the year if the therapy is approved. On the company’s first-quart

DEPRESSION

Taking antidepressants during pregnancy has little to no link to ADHD, autism

By Kristen Rogers, CNN (CNN) — Concerns about whether antidepressants cause harms to developing fetuses, including neurodevelopmental disorders, have grown in recent years. Now, a group of researchers has published the best evidence to date on links between both parents’ antidepressant use before an

DEPRESSION

New Therapy Rewires the Brain To Restore Joy in Depression Patients

Anhedonia reduces the ability to feel joy and affects nearly 90% of people with major depression. Most conventional therapies do little to treat it. Most people think of depression as a disorder defined by sadness. For millions of patients, however, one of the most disabling symptoms is different: a

DEPRESSION

Kennedy’s officials explored restrictions on antidepressants

WASHINGTON U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F. Kennedy Jr. prepared to roll out a plan to reduce their use, according to two people familiar with the discussions.

DEPRESSION

Axsome Wins FDA Nod For Expanded Use For Auvelity Beyond Depression

The U.S. Food and Drug Administration (FDA) on Thursday approved Axsome Therapeutics Inc.'s (NASDAQ: AXSM ) Auvelity (dextromethorphan HBr and bupropion HCl) for agitation tied to dementia due to Alzheimer's disease, marking a new option for a condition affecting a large share of patients . The comp

DEPRESSION

Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP ) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is developing NRX-101, an FDA-design

DEPRESSION

DefenseNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications

NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression and PTSD, announced the formation of NRx Defense Systems Inc., a Florida-based research and development subsidiary dedicated to advancing combined neuroplastic treatments using D-cycloser

DEPRESSION

Back Restore Reviews: Does It Really Work?

AUSTIN, TX / ACCESS Newswire / April 2, 2026 / Unfortunately, chronic back pain has silenced too many lives for too long. It has stolen sleep, canceled plans, ended careers, ...

DEPRESSION

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

WALTHAM, Mass.--(BUSINESS WIRE) $CYCN--Cyclerion Therapeutics, Inc. (“Cyclerion”) (Nasdaq: CYCN) and Korsana Biosciences, Inc. (“Korsana”), a privately-held biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that t

Looking for something specific? Search the full archive.